Domzalski David — SEC Form 4 filings
SEC reporting owner CIK 1727794. 16 Form 4 filings on record with FilingPulse; latest filed 2026-07-24.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-04-03 to 2026-07-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| VYNE Therapeutics Inc. (VYNE) | PRESIDENT AND CEO, Director | 16 | — | — | 16 |
Form 4 filings — Domzalski David
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-24 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 79,391 @ $0.90 | EDGAR |
| 2026-07-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 12,214 @ $0.65 | EDGAR |
| 2026-06-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Grant/award (A): 30,791 @ $0.31 | EDGAR |
| 2026-04-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 14,232 @ $0.60 | EDGAR |
| 2026-01-05 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 12,684 @ $0.58 | EDGAR |
| 2025-10-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 12,676 @ $0.34 | EDGAR |
| 2025-07-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 12,676 @ $1.65 | EDGAR |
| 2025-06-03 | 4 | VYNE Therapeutics Inc. (VYNE) | Grant/award (A): 8,681 @ $0.81 | EDGAR |
| 2025-04-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 30,498 @ $1.58 | EDGAR |
| 2025-01-23 | 4 | VYNE Therapeutics Inc. (VYNE) | Grant/award (A): 730,000 (derivative) @ $0 | EDGAR |
| 2025-01-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 24,536 @ $3.35 | EDGAR |
| 2024-12-03 | 4 | VYNE Therapeutics Inc. (VYNE) | Grant/award (A): 3,901 @ $2.10 | EDGAR |
| 2024-10-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 685 @ $1.88 | EDGAR |
| 2024-07-03 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 935 @ $1.92 | EDGAR |
| 2024-06-04 | 4 | VYNE Therapeutics Inc. (VYNE) | Grant/award (A): 4,429 @ $2.16 | EDGAR |
| 2024-04-03 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 1,004 @ $3.08 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1727794 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →